Literature DB >> 11950792

Intestinal metabolism: the role of enzyme localization in phenol metabolite kinetics.

Prajakti A Kothare1, Cheryl L Zimmerman.   

Abstract

The influence of enzyme localization and blood flow on intestinal elimination was evaluated in rats. Phenol was administered vascularly (approximately 1400 and 2500 microg) and luminally (intrajejunal bolus doses of approximately 100 and 1000 microg) to the recirculating in situ perfused intestine. The portal effluent and the reservoir were sampled. The intestinal extraction ratios for phenol at the low and high vascular doses were (mean +/- S.D., n = 3) 0.09 +/- 0.02 and 0.11 +/- 0.01, respectively. The perfusion flow rate was also varied from 5 to 12 ml/min at a vascular dose of approximately 2500 microg of phenol. The organ clearance at the lowest flow rate significantly exceeded those at the higher flow rates. The presence of a diffusional barrier at the mucosa-serosa interface was suggested. The calculated mean diffusional clearance of phenol was 1.11 ml/min. Sulfation was the predominant metabolic pathway after vascular administration of phenol. After luminal dosing, the intestinal intrinsic clearances of phenol at the low and high doses were 7.29 +/- 1.39 (n = 4) and 3.55 +/- 1.16 ml/min (n = 3), respectively, indicating saturation at the higher dose. Moreover, there was a decrease in the area under the curve ratio (metabolite/phenol) at the high luminal dose. Luminal administration, in general, produced greater glucuronidation. These data and STELLA simulations suggest that enzyme localization at both the cellular and tissue levels has a significant influence on intestinal metabolism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950792     DOI: 10.1124/dmd.30.5.586

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  1 in total

1.  Effects of Mesalazine on Morphological and Functional Changes in the Indomethacin-Induced Inflammatory Bowel Disease (Rat Model of Crohn's Disease).

Authors:  Higin Simon; Tamás Fischer; Attila Almási; Emil Fischer
Journal:  Pathol Oncol Res       Date:  2016-06-13       Impact factor: 3.201

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.